Current Report Filing (8-k)
January 11 2017 - 1:47PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
January 11, 2017
AVALON GLOBOCARE CORP.
(Exact name of registrant as specified in
its charter)
Delaware
|
000-55709
|
47-1685128
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
83 South Street, Suite 101, Freehold, New
Jersey 07728
(Address of principal executive offices)
(zip code)
646-762-4517
(Registrant's telephone number, including
area code)
Copies to:
Stephen M. Fleming, Esq.
Fleming PLLC
49 Front Street, Suite 206
Rockville Centre, New York 11570
Phone: (516) 833-5034
Fax: (516) 977-1209
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
¨
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01
|
Entry into a Material Definitive Agreement.
|
|
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory
Arrangements of Certain Officers.
|
On January 11, 2017, Avalon (Shanghai)
Healthcare Technology Ltd. (“Avalon Shanghai”), a wholly owned subsidiary of Avalon GloboCare Corp. (the “Company”),
entered into an Executive Employment Agreement with Meng Li, the Company’s COO and Secretary. Pursuant to the agreement,
Ms. Li will be employed as Chief Operating Officer and President of Avalon Shanghai through November 30, 2019, unless earlier terminated
pursuant to the terms of the agreement. During the term of the agreement, Ms. Li will be entitled to a base salary at the annualized
rate of $100,000 and will be eligible for a discretionary performance bonus, equity awards and to participate in employee benefits
plans as the Avalon Shanghai may institute from time to time at the discretion of its Board of Directors. Pursuant to the agreement,
Ms. Li may be terminated for “cause” as defined and Ms. Li may resign for “good reason” as defined. In
the event Ms. Li is terminated without cause or resigns for good reason, Avalon Shanghai will be required to pay Ms. Li all accrued
salary and bonuses, reimbursement for all business expenses and Ms. Li’s salary for one year. In the event Ms. Li is terminated
with cause, resigns without good reason, dies or is disabled, Avalon Shanghai will be required to pay Ms. Li all accrued salary
and bonuses and reimbursement for all business expenses. Under the agreement Ms. Li is subject to confidentiality, non-compete
and non-solicitation restrictions.
The preceding description of the Employment Agreement is a summary
of its material terms, does not purport to be complete, and is qualified in its entirety by reference to the Employment Agreement,
a copy of which is being filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and
Exhibits.
(d) Exhibits.
Exhibit No.
|
|
Description
|
|
|
|
10.1
|
|
Executive Employment Agreement by and between Avalon (Shanghai) Healthcare Technology Ltd. and Meng Li dated January 11, 2017
|
SIGNATURES
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
AVALON GLOBOCARE CORP.
|
|
|
|
|
|
Dated: January 11, 2017
|
By:
|
/s/ David Jin
|
|
|
|
Name: David Jin
|
|
|
|
Title: Chief Executive Officer, President and Director
|
|
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Apr 2023 to Apr 2024